NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Norcliffe Capital Limited

Norcliffe Capital Limited

Overview

Norcliffe Capital Limited is a United Kingdom-based family office that operates as a venture capital investor focusing on early-stage companies in the life sciences, MedTech, and biotechnology sectors.

Year Founded

2018

Portfolio Companies

7

Investments

Norcliffe Capital Limited investments
CompanyDateStageLead
Santersus AGDec 2025Series ALead
Laverock TherapeuticsJun 2025SeedCo-investor
DxcoverFeb 2025VC RoundCo-investor
Glen Clova ScientificApr 2024SeedLead
SMi SystemsJun 2023SeedLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersEdinburgh
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.